In the results, we found that CREB3L1 was a risk factor in BLCA, KIRC, KIRP, LIHC, SARC, SKCM and THCA, while it was a protective factor in ACC and UCEC. Here, CREB3L1 is linked to bladder transitional cell carcinoma.